IL39341A - Thieno(3,2-d)pyrimidines,their preparation and pharmaceutical compositions containing them - Google Patents

Thieno(3,2-d)pyrimidines,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL39341A
IL39341A IL39341A IL3934172A IL39341A IL 39341 A IL39341 A IL 39341A IL 39341 A IL39341 A IL 39341A IL 3934172 A IL3934172 A IL 3934172A IL 39341 A IL39341 A IL 39341A
Authority
IL
Israel
Prior art keywords
thieno
pyrimidines
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL39341A
Other languages
English (en)
Other versions
IL39341A0 (en
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19712121950 external-priority patent/DE2121950A1/de
Priority claimed from DE19712137341 external-priority patent/DE2137341A1/de
Priority claimed from DE19722215299 external-priority patent/DE2215299A1/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of IL39341A0 publication Critical patent/IL39341A0/xx
Publication of IL39341A publication Critical patent/IL39341A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL39341A 1971-05-04 1972-05-03 Thieno(3,2-d)pyrimidines,their preparation and pharmaceutical compositions containing them IL39341A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19712121950 DE2121950A1 (en) 1971-05-04 1971-05-04 Thieno(3,2-d)pyrimidine derivs - with thrombocyte aggregation inhibiting activity
DE19712137341 DE2137341A1 (de) 1971-07-26 1971-07-26 Neue thieno eckige klammer auf 3,2-d eckige klammer zu pyrimidine
DE19722215299 DE2215299A1 (de) 1972-03-29 1972-03-29 Neue thieno eckige klammer auf 3,2-d eckige klammer zu pyrimidine

Publications (2)

Publication Number Publication Date
IL39341A0 IL39341A0 (en) 1972-07-26
IL39341A true IL39341A (en) 1975-08-31

Family

ID=27183398

Family Applications (1)

Application Number Title Priority Date Filing Date
IL39341A IL39341A (en) 1971-05-04 1972-05-03 Thieno(3,2-d)pyrimidines,their preparation and pharmaceutical compositions containing them

Country Status (15)

Country Link
US (1) US3888851A (enEXAMPLES)
AT (1) AT318619B (enEXAMPLES)
AU (1) AU4181572A (enEXAMPLES)
BE (1) BE783044A (enEXAMPLES)
BG (1) BG20593A3 (enEXAMPLES)
DD (1) DD97656A5 (enEXAMPLES)
DK (1) DK129844B (enEXAMPLES)
ES (1) ES402302A1 (enEXAMPLES)
FR (1) FR2135294B1 (enEXAMPLES)
GB (1) GB1393161A (enEXAMPLES)
HU (1) HU163960B (enEXAMPLES)
IL (1) IL39341A (enEXAMPLES)
NL (1) NL7206041A (enEXAMPLES)
PL (1) PL82381B1 (enEXAMPLES)
RO (1) RO62428A (enEXAMPLES)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054656A (en) * 1975-09-10 1977-10-18 Mead Johnson & Company Thieno[2,3-d]pyrimidine antiallergic agents
US5098902A (en) * 1991-03-18 1992-03-24 Warner-Lambert Company Method of treating neurodegenerative diseases
FI943798A0 (fi) * 1992-02-19 1994-08-18 Pfizer Kasvaimenvastaisen vaikutuksen lisäämiseen tarkoitettuja heterosyklisiä yhdisteitä
KR100378937B1 (ko) 1997-10-20 2003-05-09 에프. 호프만-라 로슈 아게 바이사이클릭 키나아제 억제제
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
GB0423653D0 (en) 2004-10-25 2004-11-24 Piramed Ltd Pharmaceutical compounds
BRPI0608387A2 (pt) * 2006-04-19 2009-12-29 Boehringer Ingelheim Int compostos para o tratamento de doenças inflamatórias
CL2007001166A1 (es) 2006-04-26 2008-01-25 Piramed Ltd Compuestos derivados de pirimidina condensada, inhibidores de pi3-quinasa; procesos para preparar los compuestos; composicion farmaceutica que los comprende; uso de los compuestos en la preparacion de medicamentos; proceso para preparar la composicion farmaceutica; y kit que incluye a la composicion farmaceutica
CN101472930B (zh) 2006-04-26 2011-12-14 霍夫曼-拉罗奇有限公司 用作PI3K抑制剂的噻吩并[3,2-d]嘧啶的衍生物
PT2041139E (pt) 2006-04-26 2012-01-13 Hoffmann La Roche Compostos farmacêuticos
BRPI0717923A2 (pt) 2006-12-07 2013-10-22 Genentech In '' composto, composição farmacêutica, método para tratar um câncer, processo para a produção de uma composição farmacêutica, usos, métodos para inibir ou modular a atividade da lipídeo quinase e kit ' '
ZA200904531B (en) 2006-12-07 2010-09-29 Hoffmann La Roche Phosphoinositide 3-kinase inhibitor compounds and methods of use
EP2207781B1 (en) 2007-09-24 2012-11-28 Genentech, Inc. Thiazolopyrimidine p13k inhibitor compounds and methods of use
NZ585348A (en) * 2007-10-19 2012-02-24 Boehringer Ingelheim Int Heterocycle-substituted piperazino-dihydrothienopyrimidines
EP2214675B1 (en) 2007-10-25 2013-11-20 Genentech, Inc. Process for making thienopyrimidine compounds
GB0721095D0 (en) 2007-10-26 2007-12-05 Piramed Ltd Pharmaceutical compounds
AU2010224125B2 (en) 2009-03-12 2015-05-14 Genentech, Inc. Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
WO2010136491A1 (en) * 2009-05-27 2010-12-02 F. Hoffmann-La Roche Ag Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
EP2435438A1 (en) 2009-05-27 2012-04-04 Genentech, Inc. Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
WO2011130654A1 (en) 2010-04-16 2011-10-20 Genentech, Inc. Fox03a as predictive biomarker for pi3k/akt kinase pathway inhibitor efficacy
US20140004209A1 (en) 2010-12-22 2014-01-02 Genentech, Inc. Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
MX369175B (es) 2013-02-25 2019-10-30 Genentech Inc Métodos para detectar mutantes de akt resistentes a fármacos.
GB201410816D0 (en) * 2014-06-17 2014-07-30 Ucb Biopharma Sprl And Katholieke Universiteit Leuven Therapeutic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3259623A (en) * 1963-06-14 1966-07-05 Olin Mathieson Process for preparing 2-(secondary amino)-halogenopyrimidines
DE1470356A1 (de) * 1964-01-15 1970-04-30 Thomae Gmbh Dr K Neue Thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung
US3210368A (en) * 1964-09-29 1965-10-05 Ciba Geigy Corp Certain 2-amino-4-aryl-5-n, n-disubstituted amino-lower alkyl-thiazole compounds

Also Published As

Publication number Publication date
GB1393161A (en) 1975-05-07
DK129844C (enEXAMPLES) 1975-05-12
FR2135294A1 (enEXAMPLES) 1972-12-15
AT318619B (de) 1974-11-11
IL39341A0 (en) 1972-07-26
FR2135294B1 (enEXAMPLES) 1975-10-17
DD97656A5 (enEXAMPLES) 1973-05-12
NL7206041A (enEXAMPLES) 1972-11-07
ES402302A1 (es) 1975-04-01
RO62428A (fr) 1978-01-15
BG20593A3 (bg) 1975-12-05
US3888851A (en) 1975-06-10
BE783044A (fr) 1972-11-06
PL82381B1 (enEXAMPLES) 1975-10-31
AU4181572A (en) 1973-11-08
HU163960B (enEXAMPLES) 1973-11-28
DK129844B (da) 1974-11-25

Similar Documents

Publication Publication Date Title
IL39341A (en) Thieno(3,2-d)pyrimidines,their preparation and pharmaceutical compositions containing them
IL38687A (en) Omega-imidazolyl-omega-phenoxy-alkanones,their preparation and pharmaceutical compositions containing them
IL45492A0 (en) New pyrimidines,their preparation and pharmaceutical compositions containing them
IL36079A0 (en) 4-morpholino-thieno (3,2-d) pyrimidine derivatives,their production and pharmaceutical compositions containing them
IL35729A (en) 2-(5-nitro-2-furyl)-thieno(3,2-d) pyrimidines,their preparation and pharmaceutical compositions containing them
IL35688A0 (en) Substituted n-allyl-2-arylamino-imidazolines-(2),their preparation and pharmaceutical compositions containing them
IL35078A (en) 2-aminoalkylamino-thieno (3,2-d) pyrimidines and their salts,their preparation and pharmaceutical compositions containing them
IL39080A (en) Adenosine derivatives,their preparation and compositions containing them
IL40184A0 (en) 5-cinnamoyl-benzofurans,their preparation and pharmaceutical compositions containing them
IL39845A0 (en) Novel quinazolinone derivatives,their preparation and pharmaceutical compositions containing them
IL40800A0 (en) Thiazolo(5,4-d)pyrimidines,their preparation and pharmaceutical compositions containing them
IL40572A0 (en) Biphenylyl-butanols,their preparation and pharmaceutical compositions containing them
IL40559A0 (en) Novel pyrido(2,3-d)pyrimidines their preparation and pharmaceutical compositions containing them
IL41035A (en) N-lysergyl-3'-amino-pyridine derivatives,their production and pharmaceutical compositions containing them
IL40458A0 (en) Novel pyrimidinones and hydroxypyrimidines,their preparation and pharmaceutical compositions containing them
IL35689A (en) 2-arylamino-imidazolines-(2),their preparation and pharmaceutical compositions containing them
IL39173A (en) 2-(5-nitro-2-furyl)-thieno(2,3-d)pyrimidines and salts thereof,their preparation and pharmaceutical compositions containing them
IL40886A0 (en) Novel benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
IL40362A0 (en) Novel 4-oxo-4h-1-benzopyran and-thiabenzopyran derivatives,their preparation and pharmaceutical compositions containing them
IL41200A0 (en) Substituted 3-amino-prop-1-enes,their preparation and pharmaceutical compositions containing them
IL38593A (en) Substituted 2-arylamino-imidazoline-(2)derivatives,their preparation and pharmaceutical compositions containing them
IL33821A (en) 1,3-dihydro-5-phenyl or pyridyl-2h-1,4-benzodiazepin-2-onederivatives,their preparation and pharmaceutical compositions containing them
IL40017A0 (en) Pyrimidine derivatives,their preparation and pesticidal compositions containing them
IL39355A0 (en) Androstan-17beta-yl-acrylonitrile derivatives,their preparation and pharmaceutical compositions containing them
IL39381A0 (en) Rheadan-type alkaloids,their preparation and pharmaceutical compositions containing them